|
The Delta variant threatens to slow the jobs recovery |
The US jobs recovery is about to get a reality check. Read more » |
|
Weaker sales take a bite out of Chewy stock |
Online pet supply retailer Chewy got a huge boost during the pandemic as more consumers shopped on their phones and laptops — and adopted more kittens and puppies. Read more » |
|
Judge approves plan to dissolve OxyContin maker Purdue Pharma |
A federal bankruptcy judge ruled that Purdue Pharma, the maker of the addictive painkiller OxyContin, will be dissolved under a settlement deal and that its owners, members of the Sackler family, will pay out more than $4 billion to address the opioid epidemic that's killed more than 500,000 Americans. Read more » |
|
Welcome to September, historically the worst month for stocks |
If you're an investor who knows your market history, you might be tempted to tune out for a bit and start singing Green Day's "Wake Me Up When September Ends." The ninth month is traditionally the worst of the year for stocks. Read more » |
|
There's another big risk brewing in China |
There are a number of reasons for global investors to be keeping close watch on China, from signs its economy is slowing to Beijing's disruptive crackdown on private business. But the list doesn't end there. Read more » |
|
China's 'revolution' cost investors $3 trillion. So why aren't they running scared? |
Heavyweight global investment firms are sticking with China despite a sweeping crackdown on business by the ruling Communist Party that has wiped $3 trillion off the market value of the country's biggest companies. Read more » |
|
|